Horn Kinney 4
4 · Olema Pharmaceuticals, Inc. · Filed Jan 11, 2022
Insider Transaction Report
Form 4
Horn Kinney
Chief Business Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-01-10−5,251→ 152,289 totalExercise: $2.06Exp: 2030-06-09→ Common Stock (5,251 underlying) - Exercise/Conversion
Common Stock
2022-01-10$2.06/sh+5,251$10,838→ 7,709 total - Sale
Common Stock
2022-01-10$6.85/sh−5,251$35,969→ 2,458 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F2]The weighted average sale price for the transaction reported was $6.85, and the range of prices were between $6.60 and $7.22. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.